Biomanufacturing Technology and Partnership (BioTAP) FI supports Singapore public-sector researchers developing biomanufacturing processes and analytical capabilities for GMP readiness and industry adoption.
MTC Bioeconomy Funding Initiative: Unlocking New Carbon Sources from Sidestreams supports Singapore public sector researchers converting industrial sidestreams into cheaper carbon sources for bio-based manufacturing.
Singapore Therapeutics Development Review (STDR) 2026 (Jul) supports Singapore public-sector researchers with drug discovery and therapeutic platform funding to advance first- or best-in-class therapies.
MTC MISSION supports Singapore’s public-sector researchers with mission-driven translational R&D funding to address sector-defined problems and advance technology towards industry deployment and economic impact.
Technology Access Program (TAP) supports Delaware bioscience businesses with reduced-rate access to core-facility research technologies, helping advance bioscience research and development in the state.
Project Call 10.1 supports industry, research institutions, community colleges, and nonprofits in technology and workforce collaborations to strengthen U.S. biopharmaceutical manufacturing.